Bausch + Lomb Corporation (BLCO) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 13, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Bausch + Lomb Corporation (BLCO), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Bausch + Lomb Corporation, analysts forecast revenue rising from $5.08B in 2025 to $7.08B in 2030; the average estimate for 2030 earnings per share is $2.63; with published estimates ranging from $2.60 to $2.66; 11 analysts contribute to these figures. These are forecasts published by analysts, not results.
Analyst price targets
A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Bausch + Lomb Corporation (BLCO) forecast — frequently asked questions
What is the analyst price target for Bausch + Lomb Corporation?
Analysts covering Bausch + Lomb Corporation (BLCO) have a consensus price target of $21.75, 4.4% above the current price of $20.83. Published targets range from $17.00 to $24.00. A price target is a forecast, not a measure of value, and targets are revised often.
What are analysts forecasting for Bausch + Lomb Corporation's earnings?
The average analyst estimate for Bausch + Lomb Corporation (BLCO) earnings per share in 2030 is 2.63, with individual estimates between 2.60 and 2.66.
How much revenue is Bausch + Lomb Corporation expected to make?
Analysts forecast Bausch + Lomb Corporation (BLCO) revenue of $7.08B in 2030, based on 5 published estimates.
How many analysts cover BLCO?
11 analysts contribute estimates for Bausch + Lomb Corporation (BLCO). Thin coverage makes an average less reliable.
Analyst forecasts for other Medical - Instruments & Supplies stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.